Sign in

Naomi Hannaway

@naomihannaway.bsky.social
165 followers 126 following 12 posts

PhD Student & Research Assistant @ Dementia Research Centre, UCL. Using neuroimaging to examine Dementia with Lewy Bodies & Parkinson's Dementia. She/her.

PostsRepliesMedia
Naomi Hannaway @naomihannaway.bsky.social · 14/07/2026
Had a wonderful time at the first two days of #AAIC26! Looking forward to presenting my poster today on DTI-ALPS in #Lewy body dementia. Please come and chat to me at poster 582 to learn more
131
Reposted by Naomi Hannaway
UCL Translational Research Office @ucltro.bsky.social · 30/06/2026
We’ve renewed the UCL–Eisai partnership for another 5 years (to 2030), accelerating treatments for neurodegenerative diseases incl. Alzheimer’s, Parkinson’s & ALS. Proud to support translational research from lab to patient. Read more: tinyurl.com/4tua9kxr
134
Reposted by Naomi Hannaway
UCL Queen Square Institute of Neurology @uclqsion.bsky.social · 02/07/2026
We are celebrating 75 years of research, innovation and education with global patient impact! Watch how Queen Square’s unique combination of research, clinical care and collaboration has shaped major neurological breakthroughs and continues to drive future treatments youtu.be/QbgSKrvgQXw
Queen Square Institute of Neurology at 75 title screen
0126
Reposted by Naomi Hannaway
OHBM Trainees @ohbmtrainees.bsky.social · 16/06/2026
A huge thank you to everyone who came along and helped make Social Night such a fun evening. Special shout-out to @davemomi.bsky.social and @claraweber.bsky.social for organising the event! Here’s to the conversations and connections that make OHBM special!
0111
Naomi Hannaway @naomihannaway.bsky.social · 15/06/2026
Excited to be here at #OHBM2026! 🧠 Come and chat with me about our recent paper on DTI-ALPS in LBD, at poster 0203 on Monday and Tuesday! Looking forward to connecting with new and old faces
010
Naomi Hannaway @naomihannaway.bsky.social · 17/04/2026
Pleased to share our new paper in Alzheimer’s Research and Therapy, as part of the collection on Advances in LBD research! We found that DTI-ALPS was reduced in DLB and PDD relative to PD and controls. DTI-ALPS was also further reduced for DLB versus PD link.springer.com/article/10.1... (1/3)
link.springer.com
Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes - Alzheimer's Research & Therapy
Alzheimer's Research & Therapy - Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) are subtypes of Lewy body dementia (LBD) and overlap in symptoms and pathology....
122
Reposted by Naomi Hannaway
Dementia Researcher @dementiaresearcher.bsky.social · 15/02/2026
Join the LBD PIA ISTAART Journal Club on 29 April, 5pm London time. Hear from authors on biomarkers and survival in Lewy body dementia, with live Q and A. Don’t miss it. www.dementiaresearcher.nihr.ac.uk/event/lbd-pi...
dementiaresearcher.nihr.ac.uk
LBD PIA: ISTAART Journal Club – Meet the Author - DEMENTIA RESEARCHER
Join the LBD PIA ISTAART Journal Club on 29 April at 5pm London time. Meet the authors discussing biomarkers and survival in Lewy body dementia.
011
Reposted by Naomi Hannaway
angelikaza.bsky.social @angelikaza.bsky.social · 20/01/2026
Really excited to share first published paper of the year! Thank you to @uclbrainscience.bsky.social for highlighting: www.ucl.ac.uk/brain-scienc.... We found different organisational changes in Lewy body disease patients with dementia versus those with intact cognition, using structural gradients.
ucl.ac.uk
UCL researchers uncover distinct brain changes in Parkinson’s and Lewy body dementia
UCL researchers have used advanced brain imaging to uncover the distinct brain changes between people with Parkinson’s disease and Lewy body dementia, opening the door to more targeted treatments
1119
Reposted by Naomi Hannaway
angelikaza.bsky.social @angelikaza.bsky.social · 08/08/2025
Great to see this published @movedisorder.bsky.social movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...: We found that DTI-ALPS (a proposed indirect proxy for glymphatic clearance) is lower in Parkinson's patients who progress to poor cognitive outcomes, and correlates with cognition. 1/2
movementdisorders.onlinelibrary.wiley.com
Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI‐ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease
Background Impaired glymphatic clearance may contribute to pathological accumulations in Parkinson's (PD), but how it interacts with other processes causing dementia remains unclear. Diffusion tenso...
132
Reposted by Naomi Hannaway
Dementia Researcher @dementiaresearcher.bsky.social · 30/06/2025
Join Dr Angeliki Zarkali’s team at UCL Dementia Research Centre to support neuroimaging and clinical research into Parkinson’s and Lewy Body Dementia. Closing date: 10th July www.dementiaresearcher.nihr.ac.uk/job/research...
dementiaresearcher.nihr.ac.uk
Research Assistant: Clinical Research - DEMENTIA RESEARCHER
Join Dr Angeliki Zarkali’s team at UCL Dementia Research Centre to support neuroimaging and clinical research into Parkinson’s and Lewy Body Dementia.
022
Reposted by Naomi Hannaway
Ivelina Dobreva @ivelinadobreva.bsky.social · 20/06/2025
Pleased to share our new work. Black communities face higher Parkinson’s disease burden, but we know they remain underrepresented in research. We highlight the key barriers - distrust, stigma, and accessibility - and offer community-driven recommendations to increasing research engagement.
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
122
Naomi Hannaway @naomihannaway.bsky.social · 23/05/2025
Really pleased to share our new paper in @alzdemjournals.bsky.social. We compared plasma biomarkers and diffusion MRI between DLB, PDD and PD – to our knowledge this is the first report of plasma p-tau217 concentrations in LBD and PD! dx.doi.org/10.1002/alz....
dx.doi.org
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
INTRODUCTION Despite ongoing debate about whether Parkinson's disease (PD) dementia (PDD) and dementia with Lewy bodies (DLB) are separable diseases or a single Lewy body dementia (LBD) spectrum, th...
161
Reposted by Naomi Hannaway
Nature Biotechnology @natbiotech.nature.com · 02/05/2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease go.nature.com/44TCQ6u
go.nature.com
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease - Nature Biotechnology
Patients with Parkinson’s disease treated with fetal tissue are assessed 3 years after surgery.
244
Reposted by Naomi Hannaway
angelikaza.bsky.social @angelikaza.bsky.social · 26/02/2025
Thank you so much to @braincomms.bsky.social for highlighting our work! TLDR: white matter maters - do read the paper for more! And thank you to all amazing co-authors without whom this project would not have been possible (amongst them on bluesky: @naomihannaway.bsky.social @rimonaweil.bsky.social)
132
Reposted by Naomi Hannaway
James Catterson @scotsfriction.bsky.social · 21/11/2024
🧠 130 people now in this UK Dementia Starter Pack! 🧠 📈 (50 more than 2 days ago!) 📈 A great mix of Profs/PIs/Post-docs/PhDs/Technicians. Please re-post so it can reach a wider audience as I'm sure there are more of us out there ☺️🦋 go.bsky.app/S6FfsTp
73728